Literature DB >> 12208716

Prognosis of ischemic internuclear ophthalmoplegia.

Eric Eggenberger1, Karl Golnik, Andrew Lee, Ronel Santos, Analyn Suntay, Banu Satana, Michael Vaphlades, Charles Stevens, David Kaufman, Michael Wall, Randy Kardon.   

Abstract

OBJECTIVES: To determine the prognosis of internuclear ophthalmoplegia (INO) caused by infarction.
DESIGN: Multicenter, retrospective observational case series. PARTICIPANTS: Thirty three patients with ischemic-related INO.
METHODS: Chart review of clinical details. MAIN OUTCOME MEASURE: Resolution of diplopia in primary position.
RESULTS: Of the group, 78.8% demonstrated resolution of diplopia in primary position with an average time to resolution of 2.25 months. The presence of associated neurologic symptoms (vertigo, ataxia, dysarthria, facial palsy, pyramidal tract signs) correlated with a worse prognosis for resolution of diplopia. When performed magnetic resonance imaging (MRI) demonstrated the causative infarct in only 52% of cases; the presence of an MRI-demonstrable lesion was not significantly associated with prognosis for resolution.
CONCLUSIONS: Similar to ischemic ocular motor palsies, most ischemic-based INO become asymptomatic in primary position over 2 to 3 months. The presence of associated features correlated with persistent diplopia. MRI has limited yield in demonstrating the causative infarct.

Entities:  

Mesh:

Year:  2002        PMID: 12208716     DOI: 10.1016/s0161-6420(02)01118-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  2 in total

1.  Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.

Authors:  J P McNulty; R Lonergan; P C Brennan; M G Evanoff; R O'Laoide; J T Ryan; N Tubridy
Journal:  Clin Neuroradiol       Date:  2014-03-06       Impact factor: 3.649

2.  Comments on "Bilateral medial rectus palsy due to midbrain infarction following concussion head injury".

Authors:  Pramod Kumar Pandey; Annu Joon; Divya Kishore; Mainak Bhattacharyya
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.